We are live on ! Find out more
TG

TLP Group Portfolio holdings

AUM $6.61M Turnover 18.75%
1-Year Est. Return 12.46%
This Fund
S&P 500
This Quarter Est. Return
+18.07%
1 Year Est. Return
-12.46%
3 Year Est. Return
+42.65%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$144M
AUM Growth
-$14.9M
Cap. Flow
-$38.8M
Cap. Flow %
-26.89%
Top 10 Hldgs %
64.22%
Holding
794
New
229
Increased
159
Reduced
207
Closed
182
Avg Time Held Equity + Options
0.3 years
Top 10 Avg Time Held Equity + Options
0.5 years
Top 20 Avg Time Held Equity + Options
0.5 years
Avg Time Held Equity only
0.3 years
Top 10 Avg Time Held Equity only
0.4 years
Top 20 Avg Time Held Equity only
0.4 years

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$3.53M
2
PFE icon
Pfizer
PFE
+$2.63M
3
MRK icon
Merck
MRK
+$1.44M
4
AMGN icon
Amgen
AMGN
+$1.26M
5
LLY icon
Eli Lilly
LLY
+$976K

Sector Composition

Rank Sector Weight
1 Healthcare 36.29%
2 Miscellaneous 34.61%
3 Financials 6.7%
4 Consumer Discretionary 5.76%
5 Industrials 4.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
AIMT
1
DELISTED
Aimmune Therapeutics
AIMT
$39.7M 27.53%
1,050,000
-934,476
-47% -$30.2M
2015 Q4
8 quarters
SPY icon
2
State Street SPDR S&P 500 ETF Trust
SPY
$732B
$27.4M 19.02%
102,825
-11,383
-10% -$2.96M
2017 Q1
3 quarters
XLV icon
3
State Street Health Care Select Sector SPDR ETF
XLV
$47.4B
$6.99M 4.85%
84,579
+10,308
+14% +$850K
2017 Q3
1 quarter
IWM icon
4
iShares Russell 2000 ETF
IWM
$70.6B
$5.37M 3.72%
35,226
+23,511
+201% +$3.53M
2017 Q3
1 quarter
PFE icon
5
Pfizer
PFE
$156B
$3.8M 2.63%
110,440
+77,028
+231% +$2.63M
2017 Q3
1 quarter
SPY icon
6
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$732B
$3.04M 2.11%
791,200
+34,500
+5% +$8.97M
2016 Q2
6 quarters
MRK icon
7
Merck
MRK
$330B
$2.33M 1.62%
43,440
+25,958
+148% +$1.44M
2016 Q3
5 quarters
XLF icon
8
State Street Financial Select Sector SPDR ETF
XLF
$50.5B
$1.57M 1.09%
56,340
-7,994
-12% -$215K
2017 Q2
2 quarters
AMGN icon
9
Amgen
AMGN
$236B
$1.41M 0.97%
8,084
+7,124
+742% +$1.26M
2017 Q3
1 quarter
LLY icon
10
Eli Lilly
LLY
$1.2T
$972K 0.67%
11,507
+11,466
+27,966% +$976K
2017 Q3
1 quarter
QQQ icon
11
Invesco QQQ Trust
QQQ
$418B
$849K 0.59%
5,450
-655
-11% -$100K
2017 Q3
1 quarter
XLV icon
12
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$47.4B
$702K 0.49%
757,700
+65,900
+10% +$5.43M
2017 Q3
1 quarter
VMRK icon
13
Vivmark Residential
VMRK
$48.8B
$693K 0.48%
10,872
-4,355
-29% -$291K
2015 Q4
8 quarters
OEF icon
14
PUT
iShares S&P 100 ETF
OEF
$18.1B
$638K 0.44%
173,300
+55,800
+47% +$6.44M
2017 Q3
1 quarter
HIG icon
15
Hartford Insurance Group
HIG
$36.6B
$614K 0.43%
10,908
+2,336
+27% +$130K
2016 Q4
4 quarters
CELG
16
DELISTED
Celgene
CELG
$611K 0.42%
5,850
+2,683
+85% +$303K
2017 Q3
1 quarter
ALL icon
17
Allstate
ALL
$66.1B
$568K 0.39%
5,426
-874
-14% -$86.1K
2017 Q1
3 quarters
VNO icon
18
Vornado Realty Trust
VNO
$6.07B
$560K 0.39%
7,169
+4,420
+161% +$338K
2015 Q4
8 quarters
MS icon
19
Morgan Stanley
MS
$259B
$547K 0.38%
10,431
+2,031
+24% +$103K
2016 Q1
7 quarters
F icon
20
Ford
F
$44.6B
$541K 0.38%
43,321
+6,265
+17% +$77.1K
2015 Q4
8 quarters
URI icon
21
United Rentals
URI
$60.3B
$541K 0.38%
3,147
+134
+4% +$20.4K
2015 Q4
8 quarters
IBB icon
22
iShares Biotechnology ETF
IBB
$10.4B
$512K 0.36%
+4,800
New +$513K
2017 Q4
0 quarters
UAA icon
23
Under Armour
UAA
$1.89B
$487K 0.34%
33,771
+15,535
+85% +$224K
2017 Q2
2 quarters
JPM icon
24
JPMorgan Chase
JPM
$825B
$441K 0.31%
4,125
-1,299
-24% -$132K
2016 Q1
7 quarters
SM icon
25
SM Energy
SM
$6.71B
$437K 0.3%
+19,787
New +$399K
2017 Q4
0 quarters

Similar funds

TLP Group's Q4 2017 Portfolio in Review

As of Q4 2017, TLP Group held 794 positions worth $144M, down 9.4% from $159M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

TLP Group withdrew a net $38.8M in Q4 2017, closing 182 positions and reducing 207 holdings. Its most notable exit was Daseke Warrant, an estimated $417K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 36% a quarter earlier, followed by Miscellaneous and Financials.

Against the trend, TLP Group opened a new position in iShares Biotechnology ETF worth $512K.

  • TLP Group's largest Q4 2017 buy was iShares Biotechnology ETF: 4,800 shares worth $512K.
  • TLP Group added most to iShares Russell 2000 ETF in Q4 2017, an estimated $3.53M increase.
  • TLP Group's biggest Q4 2017 reduction was Aimmune Therapeutics, cutting an estimated $30.2M.
  • TLP Group fully exited Daseke Warrant in Q4 2017, selling an estimated $417K.
  • TLP Group's ten largest holdings make up 64% of its $144M portfolio in Q4 2017.
  • TLP Group opened 229 new positions and closed 182 in Q4 2017.
  • TLP Group's portfolio value fell 9.4% quarter-over-quarter to $144M.

Based on TLP Group's 13F filing for Q4 2017, filed 14 Feb 2018.